The Development of an Enhanced Palliative Care Pharmacy Service during the Initial COVID-19 Surge.

COVID-19 end-of-life care palliative care pharmacy service development

Journal

Pharmacy (Basel, Switzerland)
ISSN: 2226-4787
Titre abrégé: Pharmacy (Basel)
Pays: Switzerland
ID NLM: 101678532

Informations de publication

Date de publication:
09 Dec 2021
Historique:
received: 21 10 2021
revised: 05 12 2021
accepted: 07 12 2021
entrez: 23 12 2021
pubmed: 24 12 2021
medline: 24 12 2021
Statut: epublish

Résumé

The Northern Health and Social Care Trust developed an enhanced palliative care pharmacy service for acute inpatients within a large hospital in Northern Ireland during the initial COVID-19 surge. By training additional staff, there was an opportunity to increase service provision, utilising palliative care pharmacy skills to undertake activities such as the symptom management of patients, appropriate management of medicines, improved access to medicines, advice for other healthcare professionals, and supporting discharge from the hospital. The data collected showed a mean of 6.8 interventions per patient, and that, irrespective of the demand resulting from the COVID-19 pandemic, the palliative care pharmacy team had a role in improving the quality of care for palliative and end-of-life patients. Subsequent data analysis also demonstrated associated cost saving and the potential for the palliative care pharmacy team to reduce the length of stay at the hospital.

Identifiants

pubmed: 34941628
pii: pharmacy9040196
doi: 10.3390/pharmacy9040196
pmc: PMC8707779
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Pharmacy (Basel). 2021 Oct 30;9(4):
pubmed: 34842802
J Palliat Care. 1991 Winter;7(4):35-6
pubmed: 1783961
J Pain Palliat Care Pharmacother. 2014 Sep;28(3):212-5
pubmed: 25076019
Am J Health Syst Pharm. 1995 Nov 1;52(21):2419-22
pubmed: 8564606
Int J Clin Pharm. 2021 Dec;43(6):1546-1554
pubmed: 34121156
Am J Health Syst Pharm. 2017 Jan 1;74(1):e6-e8
pubmed: 28007715
BMJ Open Qual. 2019 Aug 28;8(3):e000676
pubmed: 31544164
Eur J Hosp Pharm. 2016 Mar;23(2):106-112
pubmed: 31156826
J Palliat Med. 2018 Dec;21(12):1761-1767
pubmed: 29957096
Int J Palliat Nurs. 2019 Sep 2;25(9):444-451
pubmed: 31585054
J Palliat Med. 2021 Sep;24(9):1358-1363
pubmed: 33625895
Am J Health Syst Pharm. 2002 Sep 15;59(18):1770-3
pubmed: 12298116
Cochrane Database Syst Rev. 2020 Sep 30;9:CD012780
pubmed: 32996586
J Oncol Pract. 2019 Sep;15(9):507-508
pubmed: 31369294
J Palliat Med. 2019 Jun;22(6):644-648
pubmed: 30570421
Am J Health Syst Pharm. 2015 Jun 15;72(12):999-1000
pubmed: 26025989
ONS Connect. 2015 Jun;30(2):33
pubmed: 26137826
J Health Serv Res Policy. 2008 Apr;13(2):85-91
pubmed: 18416913

Auteurs

Jaquie Hanley (J)

Antrim Area Hospital, Northern Health and Social Care Trust, BT41 2RL Antrim, Ireland.

Maureen Spargo (M)

Medicines Optimisation and Innovation Centre, Antrim Area Hospital, Northern Health and Social Care Trust, BT41 2RL Antrim, Ireland.

Joanne Brown (J)

Antrim Area Hospital, Northern Health and Social Care Trust, BT41 2RL Antrim, Ireland.

Julie Magee (J)

Antrim Area Hospital, Northern Health and Social Care Trust, BT41 2RL Antrim, Ireland.

Classifications MeSH